Rare diseases
Investigational molecules
Locations
Back to Italy36 clinical trials in Castelfranco Veneto, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer
ItalyStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
ItalyStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
ItalyStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors
ItalyStudy on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency
ItalyStudy on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer
ItalyStudy on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination
ItalyStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
ItalyStudy on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy
ItalyComparison of nilotinib versus imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission
ItalyStudy Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood-related cancers, including studies of Acute Myeloid Leukemia, Follicular Lymphoma, and Chronic Myeloid Leukemia. Clinical trials are evaluating innovative combination therapies and maintenance treatments.
Multiple trials are investigating immunotherapy approaches and targeted treatments to improve patient outcomes.
Studies addressing peripheral arterial disease and vascular complications. Research includes innovative approaches using established medications for new cardiovascular applications.
Trials focus on reducing major cardiovascular events and improving long-term patient outcomes.
Research initiatives targeting various solid tumors, including bladder cancer and biliary tract cancers. Studies are evaluating combination approaches with immunotherapy and conventional treatments.
Emphasis on developing more effective and less toxic treatment options for cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
